Physician profile
Aaron W Brothers
NPI 1477874568
$4,368.15
in general payments reported to CMS, 2019-2025
16 companies · $693 in 2025
The $693 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,192 · 2020: $24.01 · 2021: $143 · 2022: $42.44 · 2023: $914 · 2024: $359 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322 · Travel and Lodging: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.40 |
| Travel and Lodging | $644.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,084.88 | 2019-2020 | |
| Teleflex LLC | $507.30 | 2023 | Urolift |
| Medtronic, INC. | $434.38 | 2024-2025 | Altaviva, Interstim |
| C. R. Bard, INC. & Subsidiaries | $312.92 | 2023-2025 | Bard Urinary Drainage Bag |
| Intuitive Surgical, INC. | $257.21 | 2023-2024 | Da Vinci Surgical System |
| Coloplast Corp | $197.73 | 2021-2025 | Altis |
| Neotract INC. | $131.24 | 2019 | |
| Janssen Scientific Affairs, LLC | $83.53 | 2025 | |
| Janssen Biotech, INC. | $82.33 | 2021 | |
| Endo USA, INC. | $75.84 | 2024-2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $47.22 | 2025 | Gemtesa |
| Ambu INC. | $45.85 | 2021-2022 | |
| Urogen Pharma, INC. | $36.06 | 2023 | |
| Endo Pharmaceuticals INC. | $30.52 | 2022-2023 | Xiaflex, Aveed |
| Integra Lifesciences Corporation | $24.13 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17.01 | 2023 | Myrbetriq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Brothers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.